H3K4me1 drug
Evidence from:
primary |
all sources
Related entities (20)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| chromatin states | associated_with | H3K4me1 | — | 1 |
| enhancer | associated_with | H3K4me1 | — | 1 |
| H3K4me1 | expressed_in | angular gyrus | — | 1 |
| H3K4me1 | biomarker_for | AUDIT-C | — | 1 |
| H3K4me1 | biomarker_for | auditory | — | 1 |
| H3K4me1 | expressed_in | cingulate cortex | — | 1 |
| H3K4me1 | expressed_in | dorsolateral prefrontal cortex | — | 1 |
| H3K4me1 | associated_with | ENCODE project | — | 1 |
| H3K4me1 | associated_with | enhancer | — | 1 |
| H3K4me1 | interacts_with | enhancer | — | 1 |
| H3K4me1 | associated_with | H3K4me2 | — | 1 |
| H3K4me1 | associated_with | HeLa | — | 1 |
| H3K4me1 | associated_with | major depressive disorder | — | 1 |
| H3K4me1 | associated_with | PAU | — | 1 |
| H3K4me1 | associated_with | Post-Traumatic Stress Disorder | 0.00033 | 1 |
| H3K4me1 | associated_with | Roadmap Epigenomics | — | 1 |
| H3K4me1 | associated_with | SNP | — | 1 |
| H3K4me1 | expressed_in | substantia nigra | — | 1 |
| Roadmap Epigenomics consortium | associated_with | H3K4me1 | — | 1 |
| rs1409568 | interacts_with | H3K4me1 | — | 1 |
Mentioned in (49)
Papers in which this entity is mentioned.
- Advancing regulatory variant effect prediction with AlphaGenome. (2026)
- Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
- Nucleotide Transformer: building and evaluating robust foundation models for human genomics. (2025)
- Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
- Global impact of unproductive splicing on human gene expression. (2024)
- Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. (2024)
- A DNA methylation atlas of normal human cell types. (2023)
- Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. (2022)
- At the dawn: cell-free DNA fragmentomics and gene regulation. (2022)
- Folding Keratin Gene Clusters during Skin Regional Specification. (2020)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. (2019)
- Canonical Wnt5b Signaling Directs Outlying Nkx2.5+ Mesoderm into Pacemaker Cardiomyocytes. (2019)
- Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. (2019)
- Identification of common genetic risk variants for autism spectrum disorder. (2019)
- Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. (2018)
- The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder. (2018)
- Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility. (2018)
- Genome-wide association study identifies a novel locus for cannabis dependence. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. (2018)
- Neuroepigenetics and addiction. (2018)
- The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. (2018)
- Failed Progenitor Specification Underlies the Cardiopharyngeal Phenotypes in a Zebrafish Model of 22q11.2 Deletion Syndrome. (2018)
- Constrained release of lamina-associated enhancers and genes from the nuclear envelope during T-cell activation facilitates their association in chromosome compartments. (2017)
- Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
- Network analysis identifies chromosome intermingling regions as regulatory hotspots for transcription. (2017)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- DNA replication timing during development anticipates transcriptional programs and parallels enhancer activation. (2017)
- Novel genetic loci underlying human intracranial volume identified through genome-wide association. (2016)
- Nuclear organization and 3D chromatin architecture in cognition and neuropsychiatric disorders. (2016)
- Satb2 determines miRNA expression and long-term memory in the adult central nervous system. (2016)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
- A hit-and-run heat shock factor governs sustained histone methylation and transcriptional stress memory. (2016)
- Epigenomics and the structure of the living genome. (2015)
- Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser. (2015)
- An atlas of active enhancers across human cell types and tissues. (2014)
- Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation. (2014)
- EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. (2014)
- Global epigenomic reconfiguration during mammalian brain development. (2013)
- DNA methylation contributes to natural human variation. (2013)
- Landscape of transcription in human cells. (2012)
- An integrated encyclopedia of DNA elements in the human genome. (2012)
- Regulation of chromatin by histone modifications. (2011)
- An integrated ChIP-seq analysis platform with customizable workflows. (2011)
- Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. (2010)
- Long noncoding RNAs with enhancer-like function in human cells. (2010)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| h3k4me1 | drug | 49 | 108 |
| h3k4 monomethylation | drug | 1 | 1 |
| epigenetic mark of active enhancers | drug | — | — |
| histone h3 lysine 4 monomethylation | drug | — | — |